This is a preview of subscription content, log in via an institution to check access.
Notes
including patients with heart failure, coronary heart disease, cardiac arrhythmias, or hypertension.
Reference
Medicines and Healthcare products Regulatory Agency (UK). Hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease. Drug Safety Update 10: 2, No. 7, Feb 2017. Available from: URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/592989/Drug_Safety_update_-_February_2017.pdf
Rights and permissions
About this article
Cite this article
Risk of serious adverse effects with hyoscine butylbromide. Reactions Weekly 1641, 3 (2017). https://doi.org/10.1007/s40278-017-26917-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-26917-5